Thomas Jakob
Corporate Officer/Principal at AG Fuer Umsatzfinanzierung
Network origin in Thomas Jakob first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
17
| Public Company | Pharmaceuticals: Other | 17 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Thomas Jakob via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
BPC Plasma, Inc.
 BPC Plasma, Inc. Pharmaceuticals: MajorHealth Technology BPC Plasma, Inc. manufactures pharmaceutical products. It offers the hyper immunoglobulin Nabi-HB, a key product used in the prevention of hepatitis B. The company was established in 2007 and is headquartered in Boca Raton, FL. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
Biotest Pharma GmbH
 Biotest Pharma GmbH Pharmaceuticals: OtherHealth Technology Biotest Pharma GmbH engages in the manufacture and distribution of medicinal and pharmaceutical products. The company is headquartered in Dreieich, Germany. | Pharmaceuticals: Other | Chief Executive Officer Chief Executive Officer | |
| Universität zu Köln | College/University | Doctorate Degree Graduate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree Undergraduate Degree | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Director/Board Member Undergraduate Degree | |
BASF Pharma Ltd.
 BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chairman | |
| ACHILLES THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Miscellaneous Commercial Services | Director/Board Member | |
| ADMA BIOLOGICS, INC. | Biotechnology | Director/Board Member | |
| AFFIMED N.V. | Biotechnology | Director/Board Member | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Public Communications Contact | |
| ATON | Pharmaceuticals: Major | Director/Board Member | |
Heinrich Höpner GmbH & Co. KG
 Heinrich Höpner GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Heinrich Höpner GmbH & Co. KG provides business support services. The private company is based in Hamburg, Germany. The CEOs are Christoph Schröder, Thomas Schröder. The German company was founded in 1913. | Miscellaneous Commercial Services | Chief Executive Officer | |
OMOS Equity Partners GmbH
 OMOS Equity Partners GmbH Investment ManagersFinance OMOS Equity Partners GmbH provides investment services. It offers services for major change processes, development and assessment of policy options and scenarios, speech and implementation of transactions, and content solutions. The firm focuses on the health sector, industry sector, and service and logistics sector. The company was founded on July 22, 2014 and is headquartered in Berlin, Germany. | Investment Managers | Chief Executive Officer | |
Oberbergkliniken GmbH
 Oberbergkliniken GmbH Hospital/Nursing ManagementHealth Services Oberbergkliniken GmbH engages in the operation of acute care clinics. It specializes in the medical and psychotherapeutic treatment of patients that suffer from mental, psychosomatic, and psychiatric diseases. The company was founded by Edda Gottschaldt and Matthias Gottschaldt in 1988 and is headquartered in Berlin, Germany. | Hospital/Nursing Management | Chairman | |
Odewald & Compagnie Gesellschaft für Beteiligungen mbH
 Odewald & Compagnie Gesellschaft für Beteiligungen mbH Investment ManagersFinance Odewald & Compagnie Gesellschaft für Beteiligungen mbH (Odewald) is a private equity firm founded in 1997 by Dr. Jens Odewald. The firm is headquartered in Berlin. | Investment Managers | Corporate Officer/Principal | |
Neovii Biotech GmbH
 Neovii Biotech GmbH BiotechnologyHealth Technology Neovii Biotech GmbH develops and markets biopharmaceutical products in the field of transplantation. The company was founded in 2003 and is headquartered in Gräfelfing, Germany. | Biotechnology | Chief Executive Officer | |
Biotest (U.K.) Ltd.
 Biotest (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Grifols SA, Biotest (U.K.) Ltd. is a British company that supplies plasma protein products and biotherapeutic drugs. The company is based in Longbridge, UK. Our products are primarily used in the therapeutic areas of clinical immunology, haematology and intensive care medicine. Wayne Mullins has been the CEO of the company since 2013. | Pharmaceuticals: Major | Director/Board Member | |
| University of Giessen | College/University | Corporate Officer/Principal | |
| Scripps Clinic & Research Foundation | Corporate Officer/Principal | ||
| University of Bonn | College/University | Undergraduate Degree | |
Bio-Rad Medical Diagnostics GmbH
 Bio-Rad Medical Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Bio-Rad Laboratories, Inc., Bio-Rad Medical Diagnostics GmbH is a German company that provides research and development services in the field of natural sciences, engineering, and medicine. The company is based in Dreieich, Germany. The CEOs are John Bussell, Roland Michael Klug. The company was founded in 2007. | Miscellaneous Commercial Services | Chief Executive Officer | |
| BIO-RAD LABORATORIES, INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| STRATEC SE | Medical Specialties | Director/Board Member | |
| SINGULUS TECHNOLOGIES AG | Semiconductors | Director/Board Member | |
| International Institute for Management Development | College/University | Masters Business Admin | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Hoechst Roussel Vet Gmbh
 Hoechst Roussel Vet Gmbh Pharmaceuticals: OtherHealth Technology Part of Merck & Co., Inc., Hoechst Roussel Vet Gmbh develops pharmaceutical products for animals. The company is based in Hessen, Germany. Hoechst Roussel Vet was acquired by Intervet International BV from Hoechst AG on August 11, 1999 for $713.99 million. | Pharmaceuticals: Other | Corporate Officer/Principal | |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
E. Merck KG
 E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Sartorius CellGenix GmbH
 Sartorius CellGenix GmbH BiotechnologyHealth Technology CellGenix GmbH provides biopharmaceutical products. Its products include CellGro Cytokines, CellGro Supplements and Cells, Bioprocessing Containers and CellGro Serum-free Media. It is supplier of GMP (Good Manufacturing Practice) manufactured cytokines and serum-free media for cell therapy applications. The company was founded in 1994 and is headquartered in Freiburg, Germany. | Biotechnology | Corporate Officer/Principal | |
Behringwerke AG
 Behringwerke AG Pharmaceuticals: OtherHealth Technology Part of Sanofi, Behringwerke AG is a German company that produces specialty chemicals and pharmaceutical products. The company is based in Marburg, Germany. | Pharmaceuticals: Other | Corporate Officer/Principal | |
Plasma Protein Therapeutics Association
 Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | Miscellaneous Commercial Services | Director/Board Member | |
| Deutschen Gesellschaft für Immunologie | Corporate Officer/Principal | ||
| Gesellschaft für Pädiatrische Onkologie und Hämatologie | Corporate Officer/Principal | ||
| Biotest Seralc NV/SA | Director/Board Member | ||
elbion NV
 elbion NV Pharmaceuticals: MajorHealth Technology Elbion NV discovers and develops therapeutics for neurological diseases and immunological disorders. It focuses on the discovery and development of new drugs for CNS and immunological diseases. The company was founded by Dr. Thomas Kronbach and Dr. Bernd Kastler in 2002 and is headquartered in Leuven, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
Biotest US Corp.
 Biotest US Corp. Pharmaceuticals: MajorHealth Technology Biotest US Corp. manufactures pharmaceutical products. The company is headquartered in Boca Raton, FL. | Pharmaceuticals: Major | President | |
| Technical University of Berlin | College/University | Doctorate Degree | |
RIEMSER Pharma GmbH
 RIEMSER Pharma GmbH Pharmaceuticals: MajorHealth Technology RIEMSER Pharma GmbH develops, manufactures and distributes pharmaceutical products. It operates as an international specialty pharmaceutical company and core competencies cover the areas oncology, particularly supportive therapies, anti-infectives and dermatology. The company was founded in 1992 and is headquartered in Greifswald, Germany. | Pharmaceuticals: Major | Chairman |
Statistics
International
| Germany | 31 |
| United States | 12 |
| United Kingdom | 4 |
| Switzerland | 3 |
| Belgium | 3 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 8 |
| Commercial Services | 7 |
| Finance | 3 |
| Health Services | 2 |
Operational
| Director/Board Member | 50 |
| Corporate Officer/Principal | 21 |
| Chief Executive Officer | 15 |
| Chairman | 14 |
| Independent Dir/Board Member | 9 |
Most connected contacts
- Stock Market
- Insiders
- Thomas Jakob
- Company connections
